Calumet director Jennifer Straumins sells $1.32 million in stock

Calumet, Inc. (CLMT) saw a director, Jennifer Straumins, sell 100,000 shares at $13.17 on June 5, 2025, for a total of $1.32 million, while the company is currently trading above its fair value. This follows a mixed Q1 2025 report with a significant EPS miss of -$1.87 versus the -$0.38 forecast, offset by revenue exceeding expectations at $993.9 million; BofA Securities initiated a Buy rating with a $15.00 price target based on the MaxSAF renewable jet fuel project, which is expanding capacity and benefiting from DOE loans.

Analysis

Calumet, Inc. (CLMT) exhibits a complex financial and strategic picture, marked by a recent insider sale where director Jennifer Straumins divested 100,000 shares at $13.17 each, totaling $1.32 million, although she retains a significant holding of 1,084,589 shares. The stock, trading at $13.44 with a $1.16 billion market capitalization, is considered by InvestingPro to be above its Fair Value, evidenced by an elevated EBITDA multiple of 42.8x. The company also faces challenges with a significant debt burden and weak profit margins. Calumet's Q1 2025 financial performance was mixed: revenue of $993.9 million surpassed the $919.3 million forecast, yet earnings per share significantly missed expectations at -$1.87 compared to the anticipated -$0.38. Positive contributions to adjusted EBITDA came from its Specialty Products ($56.3 million) and Performance Brands ($15.8 million) segments. A key strategic initiative is the MaxSAF project, which aims to expand renewable jet fuel capacity from approximately 40 million to over 250 million gallons annually, a development that prompted BofA Securities to initiate coverage with a Buy rating and a $15.00 price target. This project benefits from temporarily interest-free loans from the Department of Energy, mitigating some financial risk. Calumet reported improved liquidity of $347 million at the end of Q1 and is actively pursuing operational cost reductions, debt management, and potential asset monetization to strengthen its balance sheet as it transitions towards sustainable energy solutions.

Key Decisions for Investors

• Investors should carefully evaluate the growth prospects tied to the MaxSAF renewable fuel project and BofA's optimistic $15.00 price target against the backdrop of the company's current overvaluation, a notable insider share sale, and a substantial Q1 earnings miss.
• Monitor the execution of the MaxSAF project and its financial contributions closely, as its success is critical to validating the company's growth trajectory and supporting its valuation, alongside progress on debt reduction and margin improvement initiatives.
• Assess the director's share sale in conjunction with her substantial remaining equity; while such sales warrant attention, the retained stake might suggest underlying confidence in the company's long-term strategic pivot to renewables.